Execs On The Move: Advisors Ascend At Angel Medical And Endonovo
Angel Medical Systems, makers of an implantable cardiac monitoring system, has assembled a medical advisory board; electroceutical therapy firm Endonovo Therapeutics has hired a strategic adviser as its CEO; and more.
You may also be interested in...
As arguments rage over whether the UK regulator has rushed its assessment of the Pfizer/BioNTech vaccine, the European Medicines Agency explains why its conditional marketing authorization approach is taking a little longer.
The IVDR implementation schedule is problematic. European notified bodies say solutions must be grasped if public health is not to suffer.
Amid several new and updated draft guidance documents and the potential approach of the first approval, interchangeability continues to be a buzzword in US biosimilars. AbbVie has projected that two Humira (adalimumab) biosimilars will hold the designation when they launch in 2023.